The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: A systematic review

Journal of Intellectual Disability Research

Volumn 52, Issue 2, 2008, Pages 107-113

  Deb, Shoumitro ^a   Chaplin, R ^a   Sohanpal, S ^a   Unwin, G ^a   Soni, R ^a   Lenotre, L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adults; Antiepileptic medication; Behaviour problem; Intellectual disability; Mood stabilizers; Systematic review

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; PLACEBO; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADULT; AGGRESSION; ANGER; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BEHAVIOR DISORDER; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DELIRIUM; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; EPILEPSY; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; IMPULSIVENESS; INTELLECTUAL IMPAIRMENT; KIDNEY FAILURE; MOOD DISORDER; OUTCOME ASSESSMENT; REVIEW; STEREOTYPY; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; HUMANS; LITHIUM COMPOUNDS; MENTAL DISORDERS; MENTAL RETARDATION; TREATMENT OUTCOME;

EID: 38049100306     PISSN: 09642633     EISSN: 13652788     Source Type: Journal    
DOI: 10.1111/j.1365-2788.2007.00965.x     Document Type: Review

References (20)

1. BNF (March 2006) British National Formulary 50. British Medical Association & Royal Pharmaceutical Society, London.
2. Brylewski J. & Duggan L. (2004) Antipsychotic medication for challenging behaviour in people with learning disability. The Cochrane Database of Systematic Reviews (Issue 3): John Wiley & Sons, Ltd., Chicester, UK.
3. Carr E. G., Horner R. H. & Turnbull A. P. (1999) Positive Behaviour Support for People with Developmental Disabilities: A Research Synthesis. American Association on Mental Retardation, Washington, DC.
4. Clarke D. J., Kelley S., Thinn K. & Corbett J. A. (1990) Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in 3 residential settings. Journal of Mental Deficiency Research 28, 229-33.
5. Craft M., Ismail I. A., Kristnamurti D., Matthews J., Regan A., Seth V. & North P. M. (1987) Lithium in the treatment of aggression in mentally handicapped patients: A double blind trial. British Journal of Psychiatry 150, 685-9.
6. Deb S. (2007) Mental health and epilepsy among adults with intellectual disabilities. In: 'Psychiatric and Behavioural Disorders in Intellectual and Developmental Disabilities' (eds N. Bouras & G. Holt), pp. 238-51. Cambridge University Press, Cambridge.
7. Deb S. & Fraser W. (1994) The use of psychotropic medication in people with learning disability: Towards rational prescribing. Human Psychopharmacology 9, 259-72.
8. Deb S., Clarke D. & Unwin G. (2006) Using Medication to Mange Behaviour Problems Among Adults with a Learning Disability: Quick Reference Guide (QRG). University of Birmingham, Mencap, London. Available at: http://www.ld-medication.bham.ac.uk (retrieved 12 January 2007).
9. Deb S., Sohanpal S., Soni S., Unwin G. & Lenotre L. (2007a) The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities. Journal of Intellectual Disability Research (in press.
10. Deb S., Unwin G. L., Soni R., Sohanpal S. & Lenotre L. (2007b) Guide to Using Psychotropic Medication for the Management of Behaviour Problems Among Adults with Intellectual Disability: Technical Document: Section 3: Systematic Reviews. University of Birmingham, Birmingham, UK. Available at: http://www.ld-medication.bham.ac.uk (retrieved 12 January 2007).
11. Friedman D. L., Kastner T., Plummer A. T., Ruiz M. Q. & Henning D. (1992) Adverse behavioural effects in individuals with mental retardation and mood disorders treated with carbamazepine. American Journal on Mental Retardation 96, 541-6.
12. Janowsky D. S., Kraus J. E., Barnhill J., Elamir B. & Davis J. M. (2003) Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviours in the intellectually disabled: An open-label retrospective study. Journal of Clinical Psychopharmacology 23, 500-4.
13. Langee H. R. (1990) Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders. American Journal on Mental Retardation 94, 448-52.
14. Pary R. (1991) Side effects during lithium treatment for psychiatric disorders in adults with mental retardation. American Journal of Mental Retardation 96, 269-73.
15. Reid A. H., Naylor G. J. & Kay D. S. G. (1981) A double-blind, placebo-controlled, crossover trial of carbamazepine in overactive severely mentally handicapped patients. Psychological Medicine 11, 109-13.
16. Ruedrich S., Swales T. P., Fossaceca C., Toliver J. & Rutkowski A. (1999) Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: A retrospective review. Journal of Intellectual Disability Research 43, 105-11.
17. Sohanpal S., Deb S., Thomas C., Soni R., Lenotre L. & Unwin G. (2007) The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: A systematic review. Journal of Intellectual Disability Research (in press.
18. Tyrer S., Walsh A., Edwards D., Berney T. & Stephens P. (1984) Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry 8, 751-5.
19. Tyrer S. P., Aronson M. E. & Lauder J. (1993) Effect of lithium on behavioural factors in aggressive mentally handicapped subjects. In: Lithium in Medicine and Biology (eds N. J. Birch, C. Padgham & M. S. Hughes), pp. 119-25. Marius Press, Carnforth.
20. Verhoeven W. M. A. & Tuinier S. (2001) Cyclothymia or unstable mood disorder? A systematic treatment evaluation with valproic acid. Journal of Applied Research in Intellectual Disabilities 14, 147-54.